Back to catalog
Peptide Companion
single
Anti-Aging
Vial: 10 mg

Adamax (10 mg Vial)

Adamax is an adamantane‑modified analog of Semax (N‑acetyl Semax Amidate), a heptapeptide derivative of ACTH(4–10) studied for nootropic and neuroprotective properties. The adamantane moiety enhances blood–brain barrier penetration and peptide stability, yielding greater potency than standard Semax. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Dose
As per research protocol
Frequency
Protocol specific
Timing
Study dependent
Duration
Research specific

Specialized research compound. Follow specific study protocols.

Dosing Schedule
WeekDaily DoseUnits (per injection) (mL)
Weeks 1–2300 µg (0.3 mg)9 units (0.09 mL)
Weeks 3–4500 µg (0.5 mg)15 units (0.15 mL)
Weeks 5–6750 µg (0.75 mg)23 units (0.23 mL)
Weeks 7–81000 µg (1.0 mg)30 units (0.30 mL)
Supplies Needed
  • •Peptide Vials (Adamax, 10 mg each):
  • •Insulin Syringes (U‑100):
  • •Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References
  • PubMed

    Semax: structure, mechanism, and therapeutic potential (ACTH analog overview)

    View source
  • PMC (NCBI)

    ACTH(4–10) analogs: neuroprotective and cognitive effects

    View source
  • Medicinal Chemistry Letters

    Adamantane modifications enhance peptide stability and CNS penetration

    View source
  • Journal of Neurochemistry (2006)

    Semax binds specific brain sites and increases BDNF protein in rat basal forebrain

    View source
  • Neuroscience and Behavioral Physiology

    BDNF and TrkB receptor modulation by ACTH analogs (neuroplasticity mechanisms)

    View source
  • PubMed

    Semax effects on dopamine and serotonin neurotransmission (mood and cognition)

    View source
  • Bulletin of Experimental Biology and Medicine

    Semax improves learning and memory in animal models

    View source
  • PubMed

    Neuroprotective effects of Semax in cerebral ischemia models

    View source
  • PubMed

    Clinical safety and tolerability of Semax in human studies (no major adverse effects)

    View source
  • MedlinePlus

    Subcutaneous injections: patient instructions and technique overview

    View source
  • NCBI Bookshelf

    Injection best practices: site rotation, aseptic technique, and administration protocols

    View source
  • PMC (Peptide Stability Review)

    Storage and handling of reconstituted peptides: temperature, light protection, and freeze–thaw considerations

    View source

Educational content adapted from peptidedosages.com. Not medical advice.